How to manage dust accumulation in tablet manufacturing

Why protecting product quality matters in tablet production

Efficient pharmaceutical tablet manufacturing depends on accurate compression, consistent product quality, and effective contamination control at every stage. High-speed compression lines can generate fine dust that sticks to tablet surfaces, affecting appearance and increasing contamination risk if it is not removed before inspection and packaging.

For manufacturers meeting GMP requirements and customer expectations, tablet finish is a visible measure of quality control. Tablet dedusting is therefore an important quality assurance and compliance step, removing built-up dust in-line without manual inspection or tablet damage.

This article explains why dust removal matters, how tablet dedusting and sieving fit into existing lines, and what quality teams should consider when selecting equipment.

Why tablet finish matters in pharmaceutical manufacturing

Healthcare professionals and patients expect tablets to be clean, uniform, and consistent. For pharmaceutical manufacturers, poor tablet finish can signal process issues that may lead to complaints, rejected batches, and increased regulatory scrutiny. Even when compression settings are within specification, residual dust can affect product quality by causing:

• Inconsistent color and surface texture across the batch
• Dust build-up in blister cavities and secondary packaging
• More cleaning stoppages during downstream processes such as coating and blister sealing

In competitive pharmaceutical markets, these issues can weaken both the product and the manufacturer’s reputation. Treating tablet finish as a quality attribute helps manufacturers address dust at source instead of relying on manual cleaning later. It also helps QA and engineering teams justify tablet dedusting equipment as part of a wider contamination control strategy.

How dust forms during tablet manufacturing

Dust and fines are a natural result of tablet compression, especially on high-speed lines. If they are not managed consistently, they can quickly become a contamination risk. Common sources include:

1. Friable formulations and high-speed presses that create fines as particles fracture.
2. Powder build-up on punches, dies, and feed frames that transfers onto tablet surfaces.
3. Burrs forming around tablet edges because of the small clearance between punch and die during ejection.
4. Chips and broken tablets that shed dust as they move through discharge paths.

Without an integrated dust extraction and tablet dedusting system, dust can build up around the press and move into downstream inspection and packaging. Over time, this can increase visual defects, cleaning needs, cleaning time, production stoppages, and environmental monitoring challenges. These issues make it harder for tablet manufacturers to maintain GMP-standard pharmaceutical contamination control.

Dust, contamination risk, and pharmaceutical contamination control

Pharmaceutical contamination control focuses on preventing unwanted particulates and residues from entering the product at any manufacturing stage. Under EU GMP and MHRA expectations, manufacturers must show that they control contamination risks and maintain clean, stable processes. Uncontrolled residual dust can:

• Increase cross-contamination risk between products that share equipment
• Challenge room classification and occupational exposure limits, especially with potent or highly active products
• Complicate cleaning validation by leaving more residue on surfaces and ventilation systems
• Cause jams, obscure sensors, or create faulty blister or strip seals further down the line

From an audit perspective, control is easier to demonstrate when tablet dedusting is defined as an in-process control with documented performance, cleaning procedures, and periodic review. QA teams can then use tablet finish and dust levels as clear factors in batch release decisions.

What is tablet dedusting, and where does it fit in tablet manufacturing?

Tablet dedusting is the controlled removal of loose powder and fines from compressed tablets before inspection, coating, or packaging. In a typical tablet manufacturing line:

• Tablets discharge from the press into tablet de-dusting equipment
• As tablets move along a spiral path or across a vibrating screen, gentle vibration and gravity separate dust from their surfaces.
• Dust is collected or extracted, while clean tablets move on to metal detection, coating, or blister packaging.

The key is to balance effective dust removal with careful product handling. Installing tablet dedusting equipment immediately after compression removes dust early, improves tablet finish, and reduces downstream cleaning. This is especially important in multi-product pharmaceutical plants, where cross-contamination control is critical. The tablet coatings market continues to expand, valued at approximately USD 899 million in 2026 and projected to grow at a CAGR of over 10% through 2032, with every coated batch requiring effective dedusting before packaging.

Russell Finex tablets dedusting equipment for quality assurance and compliance

To achieve premium product quality, pharmaceutical manufacturers should incorporate an effective tablet dedusting step immediately after tablet compression. As part of a wider contamination control strategy, removing dust at the source helps maintain a cleaner manufacturing environment. It also supports in-process quality controls and helps manufacturers meet GMP compliance requirements.

Russell Finex offers a range of tablet dedusting solutions that can address dust accumulation, depending on production requirements.

Our double-deck Russell Compact Sieve® provides a compact and space-efficient solution for tablet dedusting, separating dust and fines from compressed tablets while maintaining gentle product handling and minimizing the risk of tablet damage.

Our Finex Separator™ uses vibratory separation technology to remove dust and agglomerates from pharmaceutical granules and tablets while accurately grading material into multiple particle size fractions.

Our Finex Ultima™ combines efficient dust and agglomerate removal with a hygienic open-frame design, delivering correct grading, easy cleaning, and improved productivity for pharmaceutical manufacturing processes.

For high-capacity applications, our DeDust Pro™ upgrade can be fitted to the Finex Separator™ and Finex Ultima™, featuring a unique 360-degree gutter design that maximizes dedusting performance and improves product quality.

How to select the right dedusting equipment for your tablet manufacturing line

With options ranging from sieves to tower-style de-dusters, choosing the right dedusting technology requires input from production, engineering, and QA. The aim is to balance process demands with contamination control requirements. Key factors include:

• Tablet range: Size, shape, and fragility of current and future tablets
• Productivity: Maximum press output and any planned capacity increases
• Dust characteristics: The volume and type of fines generated during compression
• Cleaning and validation: Ease of disassembly, materials certificates, and support for cleaning validation packages
• Containment needs: Whether the product requires an open, semi-contained, or fully contained solution based on potency
• Line integration: Compatibility with existing presses, metal detectors, extraction systems, and control architecture

For multi-product UK and EMEA sites, flexibility and cleaning performance are often as important as productivity. A solution that can be validated once and then support multiple product families can deliver greater long-term value.

How tablet manufacturers benefit from using our tablet dedusting equipment

When tablet dedusting is implemented effectively, quality, operations, and compliance teams all benefit. Advantages include:

1. Improved tablet appearance – Cleaner, more uniform tablets that are easier to approve during manual or camera-based visual inspection.
2. Reduced rejects and reprocessing – Fewer dust-related issues during coating, inspection, and packaging.
3. Stronger contamination control – Enclosed design helps contain dust and prevent cross-contamination.
4. Simplified cleaning and validation – Easy-to-clean construction supports faster changeovers and cleaning validation.
5. Better audit readiness – Documented in-process dust control supports regulatory inspections and customer audits.

For manufacturers following broader contamination prevention programmes, tablet dedusting is a relatively small investment that can noticeably improve tablet finish, operator confidence, and compliance.

Test before you invest

Every tablet manufacturing process is different, so selecting the right tablet dedusting solution can be challenging. Our risk-free product testing lets you evaluate performance using your own material before investing, giving you confidence in the value it can deliver.

Speak to an expert about tablet manufacturing

Contact us at enquiriesrfl@russellfinex.com or call +44 (0) 20 8818 2000 to learn how our equipment can improve tablet quality, enhance dust control, and streamline your tablet manufacturing process.